Longitudinal peripheral radiographic case in a 69-year-old Caucasian female with mixed connective tissue disease, clinically RA-dominant. The series captures a treatment-responsive inflammatory phenotype with prior remission on hydroxychloroquine and methotrexate, flare-associated structural activity after several months off methotrexate in early 2025, and subsequent stabilization after therapy restart around September 2025. This case is useful for demonstrating interval change assessment in immune-mediated peripheral joint disease under real-world treatment interruption and re-escalation.
This RheumaView demo case highlights a longitudinal peripheral-joint pattern in mixed connective tissue disease with a rheumatoid-like phenotype and very high-titer multisystem autoantibody burden. Clinically, the patient had previously achieved remission on hydroxychloroquine plus methotrexate, then experienced a meaningful increase in disease activity after self-discontinuing methotrexate for several months in early 2025, followed by renewed stability after restarting therapy around September 2025. That timeline gives the case particular value: it is not just a static inflammatory arthropathy example, but a structured imaging snapshot of treatment response, interruption, and re-stabilization.
For clinicians, the case demonstrates how longitudinal peripheral radiographs can be organized into a cleaner, more decision-oriented view of structural behavior across timepoints, with emphasis on whether disease appears stable, progressive, reactivated, or brought back under control. For researchers and pharma audiences, it illustrates a real-world medication-interruption scenario that is common in practice but often poorly framed in routine radiology reporting. Instead of presenting only isolated findings, the case supports interval-based interpretation of structural burden in the context of disease control and therapy change. It is also useful as a demonstration of how a single case can bridge descriptive radiology, rheumatology relevance, and longitudinal analytics without collapsing into vague narrative language.
Compared with conventional imaging platforms or routine reports, the value here is not merely image storage or generic description. The case is structured to show how peripheral inflammatory disease can be tracked over time in a reproducible, clinically legible format that better reflects treatment-era evolution. It is therefore a strong showcase example for readers interested in longitudinal inflammatory arthropathy assessment, therapy-response framing, and the practical interface between radiographic structure and real-world rheumatology management.